Fedratinib reveals chemotherapeutic potential in esophageal squamous cell cancer
Man Luo(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaolan Guo(North Sichuan Medical University)
Cited by 0
Related Papers
Impaired AT2 to AT1 cell transition in PM2.5-induced mouse model of chronic obstructive pulmonary disease
|Respiratory Research|2022|64
RETRACTED: The PI3K/mTOR dual inhibitor NVP‐BEZ235 stimulates mutant p53 degradation to exert anti‐tumor effects on triple‐negative breast cancer cells
|FEBS Open Bio|2020|29
Study on myocardial toxicity induced by lead halide perovskites nanoparticles
|Nanotoxicology|2023|6